We are live on ! Find out more
HSTO

Histogen Inc. Common Stock

Delisted

HSTO was delisted on the 4th of October, 2023.

19 hedge funds and large institutions have $2.21M invested in Histogen Inc. Common Stock in 2020 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 5 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

42% more capital invested

Capital invested by funds: $1.56M → $2.21M (+$648K)

30% less funds holding

Funds holding: 2719 (-8)

60% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 5

62% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 13

Holders
19
Holders Change
-8
Holders Change %
-29.63%
% of All Funds
0.39%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
2
Reduced
5
Closed
13
Calls
Puts
Net Calls
Net Calls Change

HSTO Hedge Fund Activity: Q2 2020 in Review

19 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Histogen Inc. Common Stock (HSTO) for Q2 2020, worth a combined $2.21M — up 42% from $1.56M a quarter earlier.

Sellers outnumbered buyers: 13 funds closed out of HSTO and 5 opened new positions — a net loss of 8 holders — while 5 trimmed existing stakes and 2 added.

The largest buyer was Renaissance Technologies, adding an estimated $358K. The largest seller was JBF Capital, exiting entirely with an estimated $161K sold.

  • 19 institutional investors held Histogen Inc. Common Stock (HSTO) as of Q2 2020, down from 27 in Q1 2020.
  • Funds reported $2.21M of Histogen Inc. Common Stock stock for Q2 2020, up 42% quarter-over-quarter.
  • 5 funds opened new Histogen Inc. Common Stock positions in Q2 2020 and 13 closed out, a net change of -8 holders.
  • The largest Histogen Inc. Common Stock buyer in Q2 2020 was Renaissance Technologies, an estimated $358K added.
  • The largest Histogen Inc. Common Stock seller in Q2 2020 was JBF Capital, an estimated $161K sold.

Based on aggregated 13F filings for Q2 2020.